Biocon Gets USFDA Nod for gSaxenda, Enters US GLP-1 Weight Loss Market sheeba farhat25 Feb 2026 2:55 PM ISTNew Delhi: Biocon Limited has secured approval from the U.S. Food and Drug Administration (USFDA) for its complex formulation Liraglutide Injection,...
Once-Weekly Semaglutide Outperforms Daily Liraglutide for weight loss and HbA1c reduction in Diabetes Patients: Study Dr. Shravani Dali11 Feb 2026 9:00 AM ISTResearchers have found in a new real-world Pakistani cohort, once-weekly semaglutide achieved greater weight loss and HbA1c reduction than daily...
Medical Bulletin 29/January/2026 Dr. Bhumika Maikhuri29 Jan 2026 3:00 PM ISTHere are the top medical news for today:Exercise Key to Regaining Fitness After GLP-1-Assisted Weight Reduction: Study A new study published in...
No Link to Suicidal Thoughts: USFDA Seeks Label Change for Popular Weight-Loss Drugs Wegovy, Zepbound sheeba farhat14 Jan 2026 6:57 PM ISTThe warnings, part of their original approval, were based ​on reports of such events observed with a variety of older medicines used or studied ‌for...
GLP-1 Use Linked to Improved Survival and Fewer Complications in patients with Diabetes and Cancer: Study Dr. Shravani Dali12 Jan 2026 11:00 AM ISTResearchers have found in a new study that adults with type 2 diabetes and cancer who used GLP-1 receptor agonists had a lower risk of death compared...
Liraglutide Boosts Weight Loss After Bariatric Surgery in Patients With Poor Initial Results: Study Dr Riya Dave18 Dec 2025 8:15 PM ISTA new study published in JAMA Network Open has found that liraglutide resulted in a significant improvement in weight loss outcomes among patients in...
GLP-1 Drugs Linked to Lower Cataract and Dry AMD Risk: Study Dr Riya Dave15 Dec 2025 9:00 PM ISTRecent studies show that GLP-1 receptor agonists are associated with a significantly reduced risk of age-related cataracts and a lower risk of...
Biocon unveils Liraglutide for diabetes, obesity in Netherlands Ruchika Sharma15 Dec 2025 12:14 PM ISTBengaluru: Biocon Limited, a global biopharmaceutical company, has announced the launch of its GLP-1 peptide, Liraglutide, for diabetes (gVictoza) and...
Diabetes drugs may help older adults slow frailty, suggests study Dr. Kamal Kant Kohli5 Dec 2025 10:45 AM ISTA new study shows that older adults with type 2 diabetes who start treatment with sodium-glucose cotransporter-2 (SGLT-2) inhibitors-such as...
GLP-1 Receptor Agonists Linked to Lower Risk of Early Macular Degeneration: Study Dr Riya Dave3 Nov 2025 8:00 AM ISTResearchers have identified in a new study that exposure to glucagon-like peptide-1 receptor agonists (GLP-1RAs), commonly used for weight management,...
Comparable Cardiorenal Outcomes Among Three GLP-1 Receptor Agonists in Veterans with Type 2 Diabetes: JAMA Medha Baranwal18 Oct 2025 9:00 AM ISTUSA: A retrospective comparative effectiveness study among veterans with type 2 diabetes found that three GLP-1 receptor agonists-semaglutide,...
Regular Exercise After Weight Loss Outperforms GLP-1 Drugs in Reducing MI and Stroke Risk, suggests study Dr. Kamal Kant Kohli19 Sept 2025 9:00 AM ISTMaintaining weight loss with regular exercise rather than the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide, a drug used to treat...
